Moreover, the 36-month beta value for MLSS is 1.04. Analysts have varying opinions on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for MLSS is 48.72M and currently, short sellers hold a 0.26% of that float. On November 08, 2024, MLSS’s average trading volume was 80.84K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
MLSS) stock’s latest price update
Milestone Scientific Inc (AMEX: MLSS) has seen a decline in its stock price by -11.45 in relation to its previous close of 0.81. However, the company has experienced a -9.99% decline in its stock price over the last five trading sessions. globenewswire.com reported 2024-11-01 that Recent Medicare Price Assignment Driving Increased Access to CompuFlo Milestone Scientific to Attend New York and New Jersey Pain Medicine Congress 2024 ROSELAND, N.J., Nov. 01, 2024 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the commercial rollout of its CompuFlo® Epidural System at Hudson Specialty Care, led by renowned physician Dr. Elbaz.
MLSS’s Market Performance
Milestone Scientific Inc (MLSS) has experienced a -9.99% fall in stock performance for the past week, with a -16.75% drop in the past month, and a -24.99% drop in the past quarter. The volatility ratio for the week is 10.01%, and the volatility levels for the past 30 days are at 6.31% for MLSS. The simple moving average for the past 20 days is -11.59% for MLSS’s stock, with a -7.28% simple moving average for the past 200 days.
Analysts’ Opinion of MLSS
Maxim Group, on the other hand, stated in their research note that they expect to see MLSS reach a price target of $1.50, previously predicting the price at $3. The rating they have provided for MLSS stocks is “Buy” according to the report published on November 16th, 2018.
Maxim Group gave a rating of “Buy” to MLSS, setting the target price at $4 in the report published on December 23rd of the previous year.
MLSS Trading at -19.50% from the 50-Day Moving Average
After a stumble in the market that brought MLSS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -34.54% of loss for the given period.
Volatility was left at 6.31%, however, over the last 30 days, the volatility rate increased by 10.01%, as shares sank -16.94% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -24.60% lower at present.
During the last 5 trading sessions, MLSS fell by -9.99%, which changed the moving average for the period of 200-days by +16.43% in comparison to the 20-day moving average, which settled at $0.8145. In addition, Milestone Scientific Inc saw 4.38% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at MLSS starting from OSSER LEONARD, who sale 107,984 shares at the price of $0.93 back on Oct 22 ’24. After this action, OSSER LEONARD now owns 4,606,882 shares of Milestone Scientific Inc, valued at $100,425 using the latest closing price.
McGeehan Michael, the Director of Milestone Scientific Inc, sale 209 shares at $1.00 during a trade that took place back on Sep 24 ’24, which means that McGeehan Michael is holding 595,273 shares at $209 based on the most recent closing price.
Stock Fundamentals for MLSS
Current profitability levels for the company are sitting at:
- -0.8 for the present operating margin
- 0.72 for the gross margin
The net margin for Milestone Scientific Inc stands at -0.55. The total capital return value is set at -0.82. Equity return is now at value -58.14, with -39.92 for asset returns.
Based on Milestone Scientific Inc (MLSS), the company’s capital structure generated 0.04 points at debt to capital in total, while cash flow to debt ratio is standing at -8.03. The debt to equity ratio resting at 0.04. The interest coverage ratio of the stock is 123.63.
Currently, EBITDA for the company is -6.96 million with net debt to EBITDA at 0.82. When we switch over and look at the enterprise to sales, we see a ratio of 5.97. The receivables turnover for the company is 5.14for trailing twelve months and the total asset turnover is 0.7. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.00.
Conclusion
To wrap up, the performance of Milestone Scientific Inc (MLSS) has been bad in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
